The University of Tennessee Medical Center ( Site 3223) — Knoxville, Tennessee

Public research footprint of The University of Tennessee Medical Center ( Site 3223), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Small Cell Lung Cancer Extensive Stage · Non-small Cell Lung Cancer · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

Recently updated registry entries

NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)
NCT07513376 — A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated… (Recruiting)
NCT06901531 — A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Tennessee Medical Center ( Site 3223)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.